Join or renew today
An eclectic expert panel considered "Clinical Trials: Intersection of ethical, practical and financial" - a topic rife with undisclosed financial perks, conflicts of interest and potential benefits for participants, academic researchers, drug companies and patients.
The speakers included academic physicians Carl Elliott, M.D., Ph.D., and Jason Karlawish, M.D.; Robert (Bob) Helm, a former professional research subject; and John Fauber of the Milwaukee Journal Sentinel. Fauber, who has reported on problematic aspects of medical device research and FDA approval, organized and moderated the at-times intense discussion.
The page you have requested is available to AHCJ members only. If you are
a member, please login below.
If you're not a member, we invite you to join us. Read about member
benefits and how to join.
Please provide your user ID and password below:
~ or ~
Log in by email, using your email address: